Law Firm Brower Piven Announces Investigation of Astex Pharmaceuticals, Inc. Proposed Acquisition

STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Astex Pharmaceuticals, Inc. (“Astex”) (NASDAQ GS: ASTX) and other violations of state law by the board of directors of Astex relating to the proposed acquisition of the Company by Otsuka Pharmaceutical Co., Ltd. (“Otsuka”). The firm’s investigation seeks to determine, among other things, whether the board of directors of Astex breached their fiduciary duties by failing to maximize shareholder value.